Infectious Diseases News and Research

RSS

Low-cost, universal oral COVID-19 vaccine prevents severe respiratory illness in hamsters

A UCLA-led team has developed an inexpensive, universal oral COVID-19 vaccine that prevented severe respiratory illness and weight loss when tested in hamsters, which are naturally susceptible to SARS-CoV-2.

22 Mar 2023

End of covid emergency will usher in changes across the US health system

The Biden administration's decision to end the covid-19 public health emergency in May will institute sweeping changes across the health care system that go far beyond many people having to pay more for covid tests.

22 Mar 2023

Paxlovid is 80% effective when taken within 5 days of severe COVID

In a recent study published in The Lancet’s Infectious Diseases, researchers in the United States evaluated nirmatrelvir–ritonavir treatment effectiveness against hospitalizations and deaths among coronavirus disease 2019 (COVID-19) outpatients in the United States of America (USA).

21 Mar 2023

Vaginal sex can shape the composition of urethral microbiome in healthy men

Contrary to common beliefs, your urine is not germ free. In fact, a new study shows that the urethra of healthy men is teeming with microbial life and that a specific activity - vaginal sex - can shape its composition.

21 Mar 2023

ACTG publishes study to simplify the administration of hepatitis C treatment

The AIDS Clinical Trials Group, the world's largest HIV research network, is announcing the publication of "Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach with 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment" in the journal Clinical Infectious Diseases.

21 Mar 2023

Discovery of 16th century coronavirus in France

In a recent study published in the International Journal of Infectious Diseases, researchers conducted paleoserological tests on dental pulp samples of skeletons excavated from the Abbey Saint-Pierre in the village of Baume-Les-Messieurs in France.

20 Mar 2023

Research reports spillover of highly pathogenic avian influenza A(H5N1) into marine mammals in the northeastern United States

A recent study published in the United States (U.S.) Centers for Disease Control and Prevention (CDC) journal Emerging Infectious Diseases reported the outbreak of the highly pathogenic hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza virus among New England gray and harbor seals in the United States (U.S.)

20 Mar 2023

SARS-CoV-2 infection damages the CD8+ T cell response to vaccination

The magnitude and quality of a key immune cell's response to vaccination with two doses of the Pfizer-BioNTech COVID-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared to people without prior infection, a study has found.

20 Mar 2023

New SARS-CoV-2 Omicron XBB.1.5 variant has high transmissibility and infectivity, study finds

COVID-19 has caused significant global panic after its rapid emergence more than 3 years ago. Although we now have highly effective vaccines against the SARS-CoV-2 virus, which causes COVID-19, scientists continue to study emerging SARS-CoV-2 variants in order to safeguard public health and devise global preventive strategies against emerging variants.

20 Mar 2023

H5N1 avian influenza found in stranded harbor porpoise

In a recent study published in the United States (U.S.) Centers for Disease Control and Prevention (CDC) journal Emerging Infectious Diseases, researchers from Sweden described the detection of the hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza virus in a stranded harbor porpoise, indicating a potential spillover of this highly pathogenic avian influenza virus into cetacean species.

20 Mar 2023

Stanford researchers study causes of and treatments for long COVID

Time heals many wounds. But not all of them.

17 Mar 2023

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age.

17 Mar 2023

Real-world data on the effectiveness of Sotrovimab as a prophylactic against COVID-19

In a recent study posted in the medRxiv* preprint server, scientists assessed the efficacy of sotrovimab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) treatment.

16 Mar 2023

Research highlights the importance of ventilation and air filtration to reduce pathogen transmission

Testing of ambient air can be used to monitor the community circulation of respiratory pathogens.

16 Mar 2023

Global maternal Strep B immunization program may save millions of dollars in healthcare costs

A global maternal immunization program for group B Streptococcus - Strep B - would save millions of dollars in healthcare costs by reducing death and disability, a team led by researchers from the London School of Hygiene & Tropical Medicine has found.

16 Mar 2023

Research reveals the modulatory effect of anti-inflammatory metabolite on immune cells

Researchers have revealed the modulatory effect of the anti-inflammatory metabolite itaconate on T helper and T regulatory cells, which may lead to new therapeutic approaches to treating some autoimmune diseases.

15 Mar 2023

Researchers identify a potential treatment to prevent severe COVID-19 in high-risk patients

UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.

15 Mar 2023

WHO recommends use of pyrethroid-chlorfenapyr insecticide-treated nets to prevent malaria

The World Health Organization has updated its policy regarding the type of insecticide used on bed nets to prevent malaria.

14 Mar 2023

Insufficient sleep results in decreased antibody response to vaccination

In reviewing data from previous studies, a team lead by researchers at the University of Chicago and the French National Institute of Health and Medical Research (Inserm) found that individuals who had fewer than six hours of sleep per night in the days surrounding vaccination had a blunted antibody response.

14 Mar 2023

The burden of Clostridioides difficile infections in the United States

Researchers review existing data on Clostridioides difficile infections among United States residents.

13 Mar 2023

Infectious Diseases News and Research

Low-cost, universal oral COVID-19 vaccine prevents severe respiratory illness in hamsters

End of covid emergency will usher in changes across the US health system

Paxlovid is 80% effective when taken within 5 days of severe COVID

Vaginal sex can shape the composition of urethral microbiome in healthy men

ACTG publishes study to simplify the administration of hepatitis C treatment

Discovery of 16th century coronavirus in France

Research reports spillover of highly pathogenic avian influenza A(H5N1) into marine mammals in the northeastern United States

SARS-CoV-2 infection damages the CD8+ T cell response to vaccination

New SARS-CoV-2 Omicron XBB.1.5 variant has high transmissibility and infectivity, study finds

H5N1 avian influenza found in stranded harbor porpoise

Stanford researchers study causes of and treatments for long COVID

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

Real-world data on the effectiveness of Sotrovimab as a prophylactic against COVID-19

Research highlights the importance of ventilation and air filtration to reduce pathogen transmission

Global maternal Strep B immunization program may save millions of dollars in healthcare costs

Research reveals the modulatory effect of anti-inflammatory metabolite on immune cells

Researchers identify a potential treatment to prevent severe COVID-19 in high-risk patients

WHO recommends use of pyrethroid-chlorfenapyr insecticide-treated nets to prevent malaria

Insufficient sleep results in decreased antibody response to vaccination

The burden of Clostridioides difficile infections in the United States

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News